Phase II Study of Recombinant Interferon Alpha and Etoposide in Patients With Relapsed Osteosarcoma.
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2012
At a glance
- Drugs Etoposide; Interferon alpha
- Indications Osteosarcoma
- Focus Therapeutic Use
- 27 May 2009 Actual end date (1 Mar 2009) and additional lead trial centre added as reported by ClinicalTrials.gov record.
- 27 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Jan 2008 The expected completion date for this trial is now 1 Nov 2008.